Potential attenuation of disease progression in recurrent prostate cancer with plant-based diet and stress reduction

Integrative Cancer Therapies

Volumn 5, Issue 3, 2006, Pages 206-213

  Saxe, Gordon A ^a,c   Major, Jacqueline M ^a   Nguyen, Jacquelyn Y ^b   Freeman, Karen M ^c   Downs, Tracy M ^d   Salem, Carol E ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Complementary and alternative medicine; Disease progression; Plant based diet; Prostate; Prostate specific antigen; Prostatic neoplasms; PSA log slope; Stress reduction

Indexed keywords

HORMONE DERIVATIVE; PROSTATE SPECIFIC ANTIGEN;

ARTICLE; BONE DISEASE; BONE MASS; CANCER GROWTH; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET THERAPY; HOT FLUSH; HUMAN; LIBIDO DISORDER; MALE; METASTASIS; PILOT STUDY; PLANT; PRIORITY JOURNAL; PROSTATE CANCER; RECURRENT CANCER; STRESS; TREATMENT INDICATION; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; DIET, VEGETARIAN; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RELAXATION TECHNIQUES; RELAXATION THERAPY; STRESS, PSYCHOLOGICAL;

EID: 33746614654     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735406292042     Document Type: Article

References (27)

1. Pienta KJ. Etiology, epidemiology, and prevention of carcinoma of the prostate. In: P. C. Walsh, ed. Campbell's Urology. 7th ed. Philadelphia, Pa: Saunders; 1998:2489-2496.
2. Pound CR, Partin AW, Eisenberger MA, Chan DW, Pearson JD, Walsh PC. Natural history of progression after PSA elevation following radical prostatectomy. JAMA. 1999;281:1591-1597.
3. Patel A, Dorey F, Franklin J, deKernion JB. Recurrence patterns after radical retropubic prostatectomy: clinical usefulness of prostate specific antigen doubling times and log slope prostate specific antigen. J Urol. 1997;158:1441-1445.
4. Zagars GK, Pollack A. Kinetics of serum prostate-specific antigen after external beam radiation for clinically localized prostate cancer. Radiother Oncol. 1997;44:213-221.
5. D'Amico AV, Moul JW, Carroll PR, Sun L, Lubeck D, Chen M-H. Surrogate end-point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst. 2003;95:1376-1383.
6. Vollmer RT, Dawson NA, Vogelzang NJ. The dynamics of prostate specific antigen in hormone refractory prostate carcinoma: an analysis of Cancer and Leukemia Group B study 9181 of megestrol acetate. Cancer. 1998;83:1989-1994.
7. Messing EM, Manola J, Sarosoy M, Wilding G, Crawford ED, Trump D. Immediate hormonal therapy compared with observation after radical prostatectomy and pelvic lymphadenectomy in men with node-positive prostate cancer. N Engl J Med. 1999;341:1781-1788.
8. Mayer FJ, Crawford ED. The role of endocrine therapy in the management of local and distant recurrence of prostate cancer following radical prostatectomy or radiation therapy. Urol Clin North Am. 1994;21:707-715.
9. Newling DW. The management of hormone refractory prostate cancer. Eur Urol. 1996;29(suppl 2):69-74.
10. Kolonel L. Fat, meat, and prostate cancer. Epidemiol Rev. 2001;23:72-81.
11. Chan JM, Giovannucci EL. Dairy products, calcium, and vitamin D and risk of prostate cancer. Epidemiol Rev. 2001;23:87-92.
12. Ghosh J, Myers CE. Arachidonic acid stimulates prostate cancer cell growth: critical role of 5-lipoxygenase. Biochem Biophys Res Commun. 1997;233:418-423.
13. Chan J, Giorannucci EL. Vegetables, fruits, associated micronutrients, and risk of prostate cancer. Epidemiol Rev. 2001;23:82-86.
14. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intake and prostate cancer risk. J Natl Cancer Inst. 2000;92:61-68.
15. Brooks JD, Paton VG, Vidanes G. Potent induction of phase 2 enzymes in human prostate cancer cells by sulforaphane. Cancer Epidemiol Biomarkers Prev. 2001;10:949-954.
16. Gatenbach L, Aronsson A, Johansson B, Stromberg L. Stress stimuli-induced histopathological changes in the prostate: an experimental study in the rat. Prostate. 1987;11:69-76.
17. Cruess DG, Antoni MH, McGregor BA, et al. Cognitive-behavioral stress management reduces serum cortisol by enhancing benefit finding among women being treated for early stage breast cancer. Psychosom Med. 2000;62:304-308.
18. Sephton SE, Sapolsky RM, Kraemer HC, Spiegel D. Diurnal cortisol rhythm as a predictor of breast cancer survival. J Natl Cancer Inst. 2000;92:994-1000.
19. Miller HC. Stress prostatitis. Urology. 1988;32:507-510.
20. Kabat-Zinn J, Lipworth L, Burney R, Sellers W. Four year follow-up of a meditation-based program for the self-regulation of chronic pain: treatment outcomes and compliance. Clin J Pain. 1987;2:159-173.
21. Kabat-Zinn J, Massion AO, Kristeller J, et al. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry. 1992;149:936-943.
22. Kabat-Zinn J. Mindfulness meditation: health benefits of an ancient Buddhist practice. In: D. Goleman and J. Gurin, eds. Mind/Body Medicine. Yonkers, NY: Consumer Reports Books; 1993: 259-275.
23. Saxe GA, Hebert JR, Carmody JF, et al. Can diet in conjunction with stress reduction affect the rate of increase in prostate specific antigen after biochemical recurrence of prostate cancer? J Urol. 2001;166:2202-2207.
24. American Society for Therapeutic Radiology and Oncology Consensus Panel. Consensus statement: guidelines for PSA following radiation therapy. Int J Radiat Oncol Biol Phys. 1997;37:1035-1041.
25. Gross C, Stamey T, Hancock S, Feldman D. Treatment of early recurrent prostate cancer with 1,25-dihydroxyvitamin D3 (calcitriol). J Urol. 1998;159:2035-2039.
26. Woo TC, Choo R, Jamieson M, Chander S, Vieth R. Pilot study: potential role of vitamin D (cholecalciferol) in patients with PSA relapse after definitive therapy. Nutr Cancer. 2005;51:32-36.
27. Beer TM, Lemmon D, Lowe BA, Henner WD. High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinoma. Cancer. 2003;97:1217-1224.